ReviewWorld journal of microbiology & biotechnology2026
Recent progress in microbial succinic acid production: integrating genome engineering and fermentation strategies.
Review in World journal of microbiology & biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Succinic acid is a four-carbon dicarboxylic acid and important platform chemical with diverse applications in food and feed, pharmaceutical, textile, and bio-based polymer industries. Growing demand for sustainable and economically viable production routes has stimulated increasing interest in microbial routes for succinic acid biosynthesis as an alternative to conventional petrochemical processes. This mini-review summarizes recent advances in microbial succinic acid production, with particular emphasis on strain development, metabolic engineering, and fermentation-process optimization. Significant progress has been achieved through engineering of both native producers, Actinobacillus succinogenes, Mannheimia succiniciproducens, and Corynebacterium glutamicum and non-native production hosts, such as Escherichia coli, Klebsiella oxytoca, and several yeast species, leading to marked improvements in succinate concentration, yield, and productivity. Emerging approaches, including adaptive-laboratory evolution, systems-level omics, and CRISPR-Cas9, have enabled more precise control of carbon flux toward succinic acid biosynthesis while improving cellular tolerance to low pH and elevated succinic acid concentrations. In parallel, advances in fermentation and bioprocess strategies, particularly low-pH fermentation and enhanced CO₂ fixation, together with the valorization of renewable feedstocks such as lignocellulosic hydrolysates, offer promising opportunities to improve process feasibility and sustainability. However, their economic competitiveness remains strongly influenced by feedstock pretreatment, hydrolysis, detoxification, fermentation performance, and downstream processing requirements. Finally, current challenges and future perspectives for industrial-scale succinic acid production are discussed, highlighting the importance of integrating strain engineering with innovative bioprocess design to develop robust, economically competitive, and environmentally sustainable production platforms.
Indexed as
Identifiers
42867715What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.